Evidence map›Paper›PMID 31597707›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2019

The Second Receptor for C5a, C5aR2, Is Detrimental to Mice during Systemic Infection with

Stacey L Mueller-Ortiz, Pooja Shivshankar, Rick A Wetsel

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Enhancing prognostic prediction of invasive candidiasis among cancer patients with a serum C5a-based scoring model.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Nutrients · 2023
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stacey L Mueller-OrtizBrown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030; and.
Pooja ShivshankarBrown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030; and.
Rick A WetselBrown Foundation Institute of Molecular Medicine, Research Center for Immunology and Autoimmune Diseases, University of Texas Health Science Center at Houston, Houston, TX 77030; and Rick.A.Wetsel@uth.tmc.edu.ORCID 0000-0003-4299-5096
Brown Foundation · US

Funding

MURINE COMPLEMENT C5 DEFICIENCY--MOLECULAR BASISR01AI025011 · NIAID · WASHINGTON UNIVERSITY · PI WETSEL, RICK A. · 1987 to 2017
$4.6M
NIAID NIH HHS R01 AI025011
6 · The paper itself

Abstract

Infection with

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell SurvivalComplement C5aDisease ResistanceHost Microbial InteractionsInterferon-gammaInterleukin-12Listeria monocytogenesListeriosisLiverMaleMiceMice, Inbred C57BLMice, KnockoutC5ar1 protein, mouseC5ar2 protein, mouseComplement C5aIFNG protein, mouseInterferon-gammaInterleukin-12Receptor, Anaphylatoxin C5a

Identifiers

PMID31597707
PMCPMC6861014
OpenAlexW2980110440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.